Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Ultragenyx Fourth Quarter and Full Year 2022 Financial Results Conference Call.
Stay updated with breaking news from Gena Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good afternoon, and welcome to the Ultragenyx Fourth Quarter and Full Year 2022 Financial Results Conference Call.
Operator: Ladies and gentlemen, thank you for standing by. This is conference operator. Welcome to Zymeworks Third Quarter 2022 Results Conference Call and Webcast.
Stifel raised argenx SE (NASDAQ:ARGX) price target from $471 to $478. Stifel analyst Alex Thompson maintained a Buy rating on the stock. ...
Orchard Therapeutics plc (NASDAQ:NASDAQ:ORTX) Q3 2022 Earnings Conference Call November 14, 2022, 08:00 AM ET Company Participants Bobby Gaspar - Chief Executive Officer Braden Parker -...
SRPT earnings call for the period ending September 30, 2022.